2514953-45-6
2514953-45-6
Chemical Structure
Dropropizine-d4
Synonym(s): (±)-Dropropizine-d4; UCB-196-d4
- CAS No.: 2514953-45-6
- Formula:C13H16D4N2O2
- Molecular Weight:240.33
InChIKey: PTVWPYVOOKLBCG-KXGHAPEVSA-N
SMILES: OCC(CN1C([2H])([2H])CN(CC1([2H])[2H])C2=CC=CC=C2)O
Biological Activity: Dropropizine-d4 ((±)-Dropropizine-d4) is deuterium labeled Dropropizine. Dropropizine ((±)-Dropropizine) belongs to the phenylpiperazine group of organic compounds. Dropropizine is a peripheral antitussive agent that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors [1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dropropizine-d4 | Dropropizine-d4 ((±)-Dropropizine-d4) is deuterium labeled Dropropizine. Dropropizine ((±)-Dropropizine) belongs to the phenylpiperazine group of organic compounds. Dropropizine is a peripheral antitussive agent that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors . | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dropropizine (Standard) | 99.55% | Dropropizine (Standard) is the analytical standard of Dropropizine. This product is intended for research and analytical applications. Dropropizine ((±)-Dropropizine) is a peripheral antitussive agent that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dropropizine | 98.76% | Dropropizine ((±)-Dropropizine; UCB-196) is an orally effective, peripherally selective antitussive that inhibits the activity of peripheral receptors and afferent nerves in the respiratory tract. Dropropizine acts on the cough reflex pathway, does not pass the blood-brain barrier, and has no central nervous system side effects. Dropropizine mainly regulates the level of sensory neuropeptides and inhibits the afferent signal transmission of the cough reflex, thereby alleviating the symptoms of dry cough, and has both mild local anesthetic and antihistamine activity. Dropropizine is mainly used for symptomatic research on dry cough caused by respiratory diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
